Two diphosphorylated degrons control c-Myc degradation by the Fbw7 tumor suppressor.
Journal
Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440
Informations de publication
Date de publication:
28 Jan 2022
28 Jan 2022
Historique:
entrez:
28
1
2022
pubmed:
29
1
2022
medline:
29
1
2022
Statut:
ppublish
Résumé
c-Myc (hereafter, Myc) is a cancer driver whose abundance is regulated by the SCF
Identifiants
pubmed: 35089787
doi: 10.1126/sciadv.abl7872
pmc: PMC8797792
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
eabl7872Subventions
Organisme : NCI NIH HHS
ID : P30 CA015704
Pays : United States
Organisme : NIH HHS
ID : S10 OD023476
Pays : United States
Références
Cancer Cell. 2009 Jan 6;15(1):67-78
pubmed: 19111882
Cell. 2011 Sep 16;146(6):904-17
pubmed: 21889194
Genes Dev. 2018 Nov 1;32(21-22):1398-1419
pubmed: 30366908
Mol Cancer. 2021 Jan 4;20(1):3
pubmed: 33397405
Oncogene. 1994 Jan;9(1):59-70
pubmed: 8302604
Nature. 2001 Nov 29;414(6863):514-21
pubmed: 11734846
Cancer Cell. 2018 Nov 12;34(5):807-822.e7
pubmed: 30423298
EMBO J. 1999 Feb 1;18(3):717-26
pubmed: 9927431
Nat Rev Mol Cell Biol. 2020 May;21(5):255-267
pubmed: 32071436
Mol Cell. 2021 Feb 18;81(4):830-844.e13
pubmed: 33453168
Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):13726-13731
pubmed: 27837025
Sci Signal. 2019 Jul 16;12(590):
pubmed: 31311847
Mol Cell. 2003 Aug;12(2):381-92
pubmed: 14536078
Cancer Cell. 2016 Jan 11;29(1):75-89
pubmed: 26725216
Oncogene. 2015 Apr 30;34(18):2406-9
pubmed: 24998853
Pharmacol Res. 2019 Dec;150:104508
pubmed: 31698067
Genes (Basel). 2017 May 25;8(6):
pubmed: 28587062
Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):9085-90
pubmed: 15150404
Cell Div. 2007 Feb 13;2:7
pubmed: 17298674
J Pathol. 2012 Jun;227(2):131-5
pubmed: 22323043
Mol Cell. 2016 Jan 7;61(1):54-67
pubmed: 26687678
Nat Genet. 1993 Sep;5(1):56-61
pubmed: 8220424
Methods Enzymol. 1997;276:307-26
pubmed: 27754618
Mol Cell. 1999 Feb;3(2):169-79
pubmed: 10078200
Semin Cancer Biol. 2020 Dec;67(Pt 2):1-15
pubmed: 32113998
Oncogene. 1993 Dec;8(12):3199-209
pubmed: 8247524
Mol Cell Biol. 1994 Aug;14(8):5510-22
pubmed: 8035827
Cancer Cell. 2019 Nov 11;36(5):483-497.e15
pubmed: 31679823
Cold Spring Harb Perspect Med. 2014 Jan 01;4(1):a014357
pubmed: 24384812
Pharmacol Ther. 2020 Apr;208:107479
pubmed: 31931101
EMBO J. 2004 May 19;23(10):2116-25
pubmed: 15103331
Mol Cell Biol. 2000 Jun;20(12):4309-19
pubmed: 10825194
Cell. 2007 Jun 15;129(6):1165-76
pubmed: 17574027
Cold Spring Harb Perspect Med. 2014 Jun 02;4(6):
pubmed: 24890832
Genes Dev. 2013 Dec 1;27(23):2531-6
pubmed: 24298052
Nat Cell Biol. 2004 Apr;6(4):308-18
pubmed: 15048125
Cancer Cell. 2014 Oct 13;26(4):455-64
pubmed: 25314076
Nature. 2004 Mar 4;428(6978):77-81
pubmed: 14999283
Cancer Res. 2007 Oct 1;67(19):9006-12
pubmed: 17909001
Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3216-20
pubmed: 8386367
Cell. 2013 Jun 20;153(7):1552-66
pubmed: 23791182
J Biol Chem. 2007 Feb 23;282(8):5432-42
pubmed: 17192266
Nat Rev Cancer. 2008 Feb;8(2):83-93
pubmed: 18094723
Cell. 2012 Mar 30;149(1):22-35
pubmed: 22464321
Cold Spring Harb Perspect Med. 2014 Mar 01;4(3):
pubmed: 24591536
Oncogene. 1994 Mar;9(3):759-63
pubmed: 8108117
Biol Chem. 2006 Oct-Nov;387(10-11):1311-20
pubmed: 17081101
Nature. 2005 Aug 11;436(7052):807-11
pubmed: 16094360
Mol Cell. 2006 Feb 17;21(4):509-19
pubmed: 16483932
Cancer Res. 2011 Feb 1;71(3):925-36
pubmed: 21266350
Cell Syst. 2018 Mar 28;6(3):282-300.e2
pubmed: 29596783
Mol Cell Biol. 2006 Apr;26(7):2832-44
pubmed: 16537924
Mol Cell Biol. 2000 Apr;20(7):2423-35
pubmed: 10713166
Mol Cell. 2007 Apr 13;26(1):131-43
pubmed: 17434132
J Cell Biol. 2008 Jun 16;181(6):913-20
pubmed: 18559665
Blood. 2000 Mar 15;95(6):2104-10
pubmed: 10706881
BioDrugs. 2019 Oct;33(5):539-553
pubmed: 31392631
Cell Metab. 2005 Jun;1(6):379-91
pubmed: 16054087
Genes Dev. 2000 Oct 1;14(19):2501-14
pubmed: 11018017
Front Cell Dev Biol. 2017 Feb 23;5:10
pubmed: 28280720